|
[1]
|
蔡菁, 凌冬(2020). 帕罗西汀联合运动行为干预治疗抑郁症疗效及对γ-氨基丁酸的影响. 国际检验医学杂志, 41(20), 2485-2488.
|
|
[2]
|
陈美惠, 贾佳, 曹燕丽, 龚光明(2021). 抑郁症患者性激素异常及治疗的研究进展. 东南国防医药, 23(6), 633-636.
|
|
[3]
|
陈雪春, 陈景洲(2022). 产后抑郁与分娩前后血清Hcy、E2、5-HT、催乳素水平的相关性. 中国妇幼健康研究, 33(6), 20-24.
|
|
[4]
|
雷荣(2020). 抑郁障碍患者雌激素水平的临床意义探讨. 硕士学位论文, 唐山: 华北理工大学.
|
|
[5]
|
李剑, 高勤, 程伟, 栗伟(2022). 芍药甘草汤加减联合氯氮平治疗抗精神病药物所致高催乳素血症的疗效及对性激素的影响. 四川中医, 40(8), 120-123.
|
|
[6]
|
李玲, 谢华, 戴剑峰(2014). 下丘脑-垂体-性腺轴与抑郁症相关性的研究进展. 医学综述, 20(21), 3872-3874.
|
|
[7]
|
刘亚丽, 孟庆丰(2016). 女性脑卒中后抑郁症患者血清性激素变化及价值评价. 中国药物经济学, 11(8), 90-92.
|
|
[8]
|
马曙铮, 孟宝丽, 王宏锋(2020). 产后抑郁症患者HPA轴激素、甲状腺功能及性激素的水平分析. 国际精神病学杂志, 47(3), 504-506+513.
|
|
[9]
|
王海青, 张达明, 白云, 宋志娇(2022). 围绝经期抑郁女性5-羟色胺转运体启动子区域基因多态性及与性激素水平的相关性. 中国妇幼保健, 37(9), 1551-1554.
|
|
[10]
|
王瑞强(2022). 动机访谈干预联合帕罗西汀片治疗产后抑郁的效果. 中国妇幼保健, 37(10), 1760-1762.
|
|
[11]
|
邬朝晖, 晏洁梅, 陈桂丹, 梁新国(2022). 围绝经期女性睡眠质量、情绪障碍及性激素水平与认知功能相关性分析. 中国医学工程, 30(7), 65-68.
|
|
[12]
|
中国神经科学学会精神病学基础与临床分会精神分裂症临床研究联盟(2021). 抗精神病药所致高泌乳素血症干预对策的专家共识. 中华精神科杂志, 54(3), 163-169.
|
|
[13]
|
Borgsted, C., Høgh, S., Høgsted, E. S., Fonnesbech-Sandberg, L., Ekelund, K., Albrechtsen, C. K. et al. (2022). The Role of Central Serotonergic Markers and Estradiol Changes in Perinatal Mental Health. Acta Psychiatrica Scandinavica, 146, 357-369.[CrossRef] [PubMed]
|
|
[14]
|
Bukstein, O. G. (2022). Screening for Adolescent Depression and Suicide Risk. JAMA, 328, 1504-1505.[CrossRef] [PubMed]
|
|
[15]
|
Chen, Z., Shen, X., Tian, K., Liu, Y., Xiong, S., Yu, Q. et al. (2020). Bioavailable Testosterone Is Associated with Symptoms of Depression in Adult Men. Journal of International Medical Research, 48.[CrossRef] [PubMed]
|
|
[16]
|
de Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C., & Pierroz, D. D. (2016). Revised Global Consensus Statement on Menopausal Hormone Therapy. Maturitas, 91, 153-155.[CrossRef] [PubMed]
|
|
[17]
|
Delgado-Alvarado, M., Tordesillas-Gutierrez, D., Ayesa-Arriola, R., Canal, M., Ortiz-García de la Foz, V., Labad, J., & Crespo-Facorro, B. (2019). Plasma Prolactin Levels Are Associated with the Severity of Illness in Drug-Naive First-Episode Psychosis Female Patients. Archives of Women’s Mental Health, 22, 367-373.[CrossRef] [PubMed]
|
|
[18]
|
Eck, S. R., & Bangasser, D. A. (2020). The Effects of Early Life Stress on Motivated Behaviors: A Role for Gonadal Hormones. Neuroscience & Biobehavioral Reviews, 119, 86-100.[CrossRef] [PubMed]
|
|
[19]
|
Elgellaie, A., Larkin, T., Kaelle, J., Mills, J., & Thomas, S. (2021). Plasma Prolactin Is Higher in Major Depressive Disorder and Females, Associated with Anxiety, Hostility, Somatization, Psychotic Symptoms and Heart Rate. Comprehensive Psychoneuroendocrinology, 6, Article ID: 100049.[CrossRef] [PubMed]
|
|
[20]
|
Kundakovic, M., & Rocks, D. (2022). Sex Hormone Fluctuation and Increased Female Risk for Depression and Anxiety Disorders: From Clinical Evidence to Molecular Mechanisms. Frontiers in Neuroendocrinology, 66, Article ID: 101010.[CrossRef] [PubMed]
|
|
[21]
|
Margolese, H. C. (2000). The Male Menopause and Mood: Testosterone Decline and Depression in the Aging Male—Is There a Link? Journal of Geriatric Psychiatry and Neurology, 13, 93-101.[CrossRef] [PubMed]
|
|
[22]
|
McHenry, J., Carrier, N., Hull, E., & Kabbaj, M. (2014). Sex Differences in Anxiety and Depression: Role of Testosterone. Frontiers in Neuroendocrinology, 35, 42-57.[CrossRef] [PubMed]
|
|
[23]
|
Smith, K. (2014). Mental Health: A World of Depression. Nature, 515, 181.[CrossRef] [PubMed]
|
|
[24]
|
Torner, L. (2016). Actions of Prolactin in the Brain: From Physiological Adaptations to Stress and Neurogenesis to Psychopathology. Frontiers in Endocrinology (Lausanne), 7, Article No. 25.[CrossRef] [PubMed]
|